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For poultry producers, chronic low-grade intestinal inflammation has a negative impact on
productivity by impairing nutrient absorption and allocation of nutrients for growth.
Understanding the triggers of chronic intestinal inflammation and developing a non-
invasive measurement is crucial to managing gut health in poultry. In this study, we
developed two novel models of low-grade chronic intestinal inflammation in broiler
chickens: a chemical model using dextran sodium sulfate (DSS) and a dietary model
using a high non-starch polysaccharide diet (NSP). Further, we evaluated the potential of
several proteins as biomarkers of gut inflammation. For these experiments, the chemical
induction of inflammation consisted of two 5-day cycles of oral gavage of either 0.25mg
DSS/ml or 0.35mg DSS/ml; whereas the NSP diet (30% rice bran) was fed throughout the
experiment. At four times (14, 22, 28 and 36-d post-hatch), necropsies were performed to
collect intestinal samples for histology, and feces and serum for biomarkers quantification.
Neither DSS nor NSP treatments affected feed intake or livability. NSP-fed birds exhibited
intestinal inflammation through 14-d, which stabilized by 36-d. On the other hand, the
cyclic DSS-treatment produced inflammation throughout the entire experimental period.
Histological examination of the intestine revealed that the inflammation induced by both
models exhibited similar spatial and temporal patterns with the duodenum and jejunum
affected early (at 14-d) whereas the ileum was compromised by 28-d. Calprotectin (CALP)
was the only serum protein found to be increased due to inflammation. However, fecal
CALP and Lipocalin-2 (LCN-2) concentrations were significantly greater in the induced
inflammation groups at 28-d. This experiment demonstrated for the first time, two in vivo
models of chronic gut inflammation in chickens, a DSS and a nutritional NSP protocols.
Based on these models we observed that intestinal inflammation begins in the upper
segments of small intestine and moved to the lower region over time. In the searching for aorg May 2021 | Volume 12 | Article 6766281
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importantly, calprotectin has a great potential as a novel biomarker for poultry
measured both in serum and feces.Keywords: calprotectin, DSS, gut health, lipocalin, models of intestinal inflammation, ISI indexINTRODUCTION
Antibiotics used as growth promoters (AGP) have successfully
controlled dysbiosis and enteropathogens for the past 50 years
(1). However, the recent increase in worldwide non-AGP poultry
production is challenging the industry in management, health, and
animal welfare due to the increase of enteric and systemic diseases
(2, 3). One of the most accepted theories of AGP mechanism is its
role in reducing low-level inflammation (4) and immunologic stress
(5) that can be caused by environmental factors, pathogens, and
feed ingredients (6). Therefore, removing AGP may increase the
inflammatory level of the non-AGP flocks and reduce their
performance, which raises the importance of understanding
intestinal health and applied practices to its promotion (7).
Despite the importance of studying chronic gut inflammation
(8), there is a lack of a practical model to induce a low-grade
chronic response in broilers that would mimic field situations.
Among the developed models in poultry species, most produce
strong negative effects causing clinical signs such as the reduction
in body weight (9–13). Other models are difficult to replicate or
apply in large experiments due to complex methodology (14),
including chemicals furnished via drinking water (10), injections
(11, 13), or pathogen-specific challenge. Therefore, there is a
need for an easily replicated research model that will best mimic
the intestinal response in the field.
A nutritional model to produce gut inflammation would be
advantageous because the diet would induce a non-specific
immune response, also it is easier to apply and might
resembles industry situations. Rice bran is an alternative
ingredient for energy used in animal nutrition. Compared to
other alternatives, such as wheat, rice has higher metabolizable
energy and lower fiber content (15). Although rice bran is not
considered a soluble ingredient (16), it still has a considerable
percentage of fiber, one of the highest phytate content in
vegetable ingredients (1.37%), and a large amount of lipids
(14.2%) that may suffer peroxidation (15, 17). The negative
effects of rancid lipids and phytate on the intestinal mucosa are
well known (6, 18–21). Thus, diets with rice bran inclusion may
provoke an intestinal challenge in which the degree will vary with
the inclusion rate of the ingredient. Alternatively, chemical
models of intestinal inflammation also produce a non-specific
response that can be used as a positive control in certain
situations, although they may not be identical to industry
situations and should be used with caution. Dextran sodium
sulfate (DSS) is a polymer widely used in rodent studies to
produce colitis. DSS has previously been shown to induce
intestinal inflammation in chickens. Oral gavage of DSS had
been shown to induce loose stools, histology alterations and
weight loss (9, 10, 22). However, most of the rodents and all theorg 2DSS chicken protocols produced an acute inflammatory response
in the intestine. To study chronic intestinal disease, such as
Crohn´s and inflammatory bowel diseases, Bento and
collaborators (23) developed a protocol that produced chronic
intestinal inflammation after subjecting mice through to two
cycles of DSS via oral gavage.
In addition to establishing a chronic inflammation model, the
poultry industry seeks reliable non-invasive biomarker(s) of
intestinal inflammation. Several potential biomarkers have
already been evaluated in the chicken, such as lipocalin
(LCN2), alpha-1 antitrypsin, intestinal alkaline phosphatase,
superoxide dismutase, fibronectin (13), and ovotransferrin (24,
25). However, only a few (ovotransferrin, lipocalin and
fibronectin) have shown promising but inconsistent results in
previous research. Studies in human medicine have proven that
fecal concentration of calprotectin, a protein present in
neutrophils, monocytes, and macrophages, is a non-invasive
method to evaluate the gut inflammation process (26, 27).
Recently, calprotectin has been used to aid diagnosis of colonic
diseases, for monitoring disease and cancer, and to evaluate
efficacy of treatments (28–31). To our knowledge, there have
been no studies quantifying levels of calprotectin in poultry
excreta or fluids. However, increased gene expression of
calprotectin was identified in the intestine of broilers exposed
to Salmonella enterica (32), Eimeria maxima and Clostridium
perfringens (33), and heat stress (34). Thus, we believe
calprotectin has the potential to serve as a biomarker of
inflammation in the small intestine of broilers.
Therefore, for this study, we hypothesized that a diet with
high inclusion of rice bran or a challenge with DSS based on the
Bento et al. (33) protocol have the potential to induce a low-
grade chronic inflammation in the intestine of chickens. In the
current study, we utilized a) a diet with 30% of rice bran and
b) two cycles of DSS oral administration at two different levels,
to produce a model of low-grade intestinal inflammation in
broilers. Moreover, we evaluated the effect of the challenges
overtime in the small intestine and analyzed several biomarkers
in the blood and excreta of chickens. This allowed us to:
(1) identify two simplistic low-grade inflammation models
without inducing major clinical signs and/or a pathogenic
infection (2), evaluate calprotectin as a novel biomarker, and
(3) quantify in low-grade chronic inflammation model potential
biomarkers previously reported.MATERIAL AND METHODS
The experiment was conducted in accordance with guidelines set
by the United States Department of Agriculture Animal CareMay 2021 | Volume 12 | Article 676628
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conducted at the Agricultural Research Service Facility of the
United States Department of Agriculture (ARS-USDA), College
Station, Texas, US.
To evaluate the two different intestinal inflammation models, a
total of 180 Cobb male by-product day-of-hatch chickens were
randomly assigned to four experimental treatment groups with
three repetitions of 15 birds each. The treatments were: (1) Control
(CNT) with a corn/soybean meal standard diet; the second and
third groups received control diet and were submitted to two
cycles of (2) 0.25mg/ml of DSS (25DSS), or (3) 0.35mg/ml of DSS
(35DSS), respectively; and (4) the fourth group had a high non-
starch polysaccharide diet (NSP) (30% of rice bran) (Table 1). DSS
was used as a chemical inducer of intestinal inflammation. The
birds in 25DSS- and 35DSS-treated groups received a DSS solution
administrated via oral gavage in two cycles of 5 consecutive days,
interrupted by a recovery period of 9 days as described for a
murine model of intestinal chronic inflammation (23). The first
cycle lasted from day 9 to day 14 of age; the second cycle was
applied from day 23 to day 27 of age (Figure 1). Birds in the NSP
treatment received feed with 30% of rice bran inclusion during the
entire experimental period (1 to 36-d of age).
The different diets offered were iso-energetic, iso-nitrogenous,
and formulated tomeet or exceed the broiler’s requirements (Cobb
manual, 2018) (Table 2). Two feeding phases were used: starter
(1-21 days) and grower (21-36 days). Dextran sodium sulfate
solutions were produced by solubilizing DSS (MW ca 40,000;
Sigma Aldrich) in distilled water to the desired concentrations.
Chickens were placed from day 1 to 36 of age on 0.91 x 1.21
m2 pens and a minimum of 0.074m2/bird was maintained during
the whole experimental period; the floor was covered with new
pine shavings. Water and feed were offered ad libitum andFrontiers in Immunology | www.frontiersin.org 3environmental conditions were maintained for each growing
phase according to the Cobb manual recommendations (2018).
Necropsy and Sampling
Necropsies were performed on days 14, 22, 28 and 36 of age and
intestinal tissue, blood, and fecal samples were collected to evaluate
the gastrointestinal tract (GIT) inflammation (Figure 1). At
necropsy, two birds from each pen (6 birds from each treatment)
were randomly selected for sample collection. Initially, blood was
collected in serum tubes from the jugular vein, and finally the bird
was euthanized by cervical dislocation. The collected blood tubs
were laid flat for clotting (at least for 30 min) and the serum was
separated and collected after centrifugation (15 min on 3000 rpm)
and stored at -20°C for further analyses.
Following euthanasia, each carcass was systematically
evaluated to identify the health status and physical condition
of the gastrointestinal tract based on the “I See Inside” (ISI)
methodology (35). The intestine (duodenum, jejunum, ileum
and cecum) and GIT-associated organs (liver, yolk,
proventriculus, gizzard, pancreas) were evaluated grossly as
described (35). Several macroscopic characteristics were scored
on a 0-3 scale and the scores were then multiplied by impact
factors (1–3), depending on their importance (in detail in Table
1 of “Supplemental Data”). The ISI macro total score (sum of all
observed lesions) in the study can reach 78, stemming from a
total intestinal score of 54 and a total GIT-associated organs of
24. The higher the ISI score, the worse the GIT health status.
During the necropsy, samples of duodenum, jejunum and ileum
were collected for posterior histological analysis. For the tissue
collection, intestinal anatomy was used to ensure sampling of a
similar segment in all birds. Duodenum samples (5cm) were taken
1cm caudal the duodenal loop. Meckel´s diverticulum was used toTABLE 1 | Experimental treatments.
Treatment Abbreviation Diet Intestinal Challenge
Control CNT Corn/soybean meal standard diet No
0.25mg/ml of DSS 25DSS Corn/soybean meal standard diet 0.25mg/ml of DSS oral gavage daily from 9 to14-d and 23 to 27-d
0.35mg/ml of DSS 35DSS Corn/soybean meal standard diet 0.35mg/ml of DSS oral gavage daily from 9 to14-d and 23 to 27-d
High NSP NSP 30% of rice bran inclusion High NSP dietNSP, non-starch polyssacharide; CNT, Control; DSS, Dextran sodium sulfate.FIGURE 1 | Experimental timeline. Male by-product day-of-hatch chickens were divided in four experimental treatments and raised up to 36 days. The broilers
assigned to treatments with DSS challenge received 0.25mg/ml or 0.35mg/ml of DSS via oral gavage everyday from 9 to 14-d and 23 to 27-d (induction phase
period represented with red). After each DSS cycle animals were allowed to a 9 days recovery period (from 14 to 23-d and 27 to 36-d, marked in green). Birds in the
NSP treatment received a diet with 30% of rice bran from 1 to 36-d. Animals in the control group were not submitted to any challenge. Necropsies were performed
on days 14, 22, 28 and 36 for collection of intestinal tissue, blood, and fecal samples.May 2021 | Volume 12 | Article 676628
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middle of each segment (5cm). The intestinal samples were washed
with 0.9% NaCl solution and fixed in 10% buffered formalin.
Fecal Sampling
Fresh excreta samples were collected at 28 and 36-d from 2 birds
per repetition (6 samples for each treatment), immediately
frozen in liquid nitrogen and stored at -80°C. For downstream
ELISA array, 0.4 g of excreta was vortexed with 4 ml of PBS and
centrifuged for 20 min at 4°C at 3000 rpm. The supernatant was
removed and stored at -20°C for posterior assays.
ELISA Analysis
For the biomarker searching concentration of calprotectin (avian
MRP-126), lipocalin, S100 protein, hypoxia inducible factor- 1Frontiers in Immunology | www.frontiersin.org 4subunit alpha (HIF1a), lipopolysaccharides (LPS) and
ovotransferrin (OVT) were quantified using the fecal
homogenate and/or serum at different time points (Table 3).
All biomarkers were quantified with ELISA kits from
MyBiosource Inc. (San Diego, CA-USA).
Histology and I See Inside Methodology
The intestinal samples stored in formalin were dehydrated,
infiltrated, and embedded in paraffin following standard
histological practices. Paraffin blocks were cut into 5 mm
sections and stained with hematoxylin and eosin.
For evaluation of microscopic alterations, 20 villi sections
per bird were evaluated at 10X magnification (using 40X
magnification to confirm alterations) by a treatment blinded
person using an optical microscope (Nikon Eclipse E200,TABLE 2 | Ingredients and calculated nutritional composition of experimental diets.
Ingredients (%) Starter (1-21 d) Grower (22-36 d)
Control High NSP Control High NSP
Corn 58.87 31.08 65.97 38.185
Soybean meal1 34.75 29.93 27.87 22.515
Rice bran 0 30 0 30
Soybean oil 2.40 5.62 2.74 5.95
Monocalcium phosphate 1.72 1.333 1.42 1.03
Limestone 1.08 1.255 0.93 1.10
NaCl 0.37 0.35 0.37 0.35
DL-Methionine 0.35 0.35 0.27 0.30
L-Lysine HCl 0.22 0.29 0.18 0.259
L-Threonine 0.098 0.165 0.012 0.079
Choline chloride 0.05 0.05 0.05 0.05
Vitamin premix2 0.05 0.05 0.1 0.1
Mineral premix3 0.03 0.03 0.05 0.05
Calculated composition
Metabolizable energy (kcal/kg) 2990 2990 3100 3100
Crude protein (%) 22 22 19 19
Lysine dig. (%) 1.22 1.22 1.02 1.02
Methionine (%) 0.61 0.63 0.53 0.55
Meth. + cysteine dig. (%) 0.91 0.91 0.80 0.80
Threonine dig. (%) 0.83 0.83 0.66 0.66
Av. Phosphorus (%) 0.45 0.45 0.38 0.38
Calcium (%) 0.90 0.90 0.76 0.76
Potassium (%) 0.92 1.14 0.79 1.02
Sodium (%) 0.16 0.16 0.16 0.16May 2021 | Volume 12 | Arti1 Soybean meal 49% of crude protein.
2 Composition of minimum (per kg of feed): Vit A 8,818,342 IU; Vit D3 3,086,420 IU; Vit E 3,674 IU; Vit B12 130 mg; Vit K 1,177mg; Vit B2 4,775 mg; pantothenic acid 16,168 mg; Vit B1
2,350 mg; Vit B3 36,742 mg; Vit B6 5,732 mg; folic acid 1.1,398 mg; choline 104,460 mg; biotin 441mg.
3 Minimum of Fe 12%; Cu 1.4%; I 800ppm; Zn 12%; Mn 173.0 mg; Mg 12%.
Av., available; dig, digestible.TABLE 3 | Proteins quantified in serum and/or feces of broilers at 14, 22, 28 or 36 days post-hatch by ELISA.
14-d 22-d 28-d 36-d ELISA catalog #
Calprotectin (avian MRP126) Serum Serum Feces Feces MBS1601938
Lipocalin Serum Serum Serum and Feces – MBS005459
S100A – – Feces Feces MBS2504874
HIF1a – – Feces Feces MBS287105
Ovotransferrin – – Feces – MBS2533639
LPS Serum Serum Serum MBS268415S100A, S100A protein; HIF1a, hypoxia inducible factor-1 subunit alpha; LPS, lipopolysaccharides.cle 676628
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methodology (patent INPI BR 1020150036019), was used to
measure histologic alterations on the intestine (36), and a final
intestinal health index was produced. A score (0–3) was given to
each alteration depending on the extent of the lesion: the greater
the lesion, the higher the score. The score was then multiplied by
an impact factor (IF; 1-3) which is based on the consequence of
alteration on the organ functionality. The final ISI index was then
calculated as the sum of all alteration index:
ISI index =  o score  IF
The alterations evaluated, and their impact factor were:
lamina propria thickness*(2), epithelial thickness*(1),
enterocytes proliferation*(1), inflammatory cell infiltration in
the epithelium*(1), inflammatory cell infiltration in the lamina
propria*(3), goblet cells proliferation*(2), congestion*(2), and
the presence of Eimeria sp. oocysts*(3). Therefore, animals with a
high final ISI index had worse intestinal health. For statistical
analysis each villus was considered as a replicate.Statistical Analysis
Data were analyzed accordingly to a complete randomized
design. At first, normality of all the data was verified through
Shapiro-Wilk’s test and variables with non-normal distribution
were analyzed by Kruskal Wallis test, as all data generated by the
microscopic and macroscopic ISI evaluation. Then, data with
normal distribution were analyzed using ANOVA (P-value
<0.05), and means were compared by Tukey. Dunnet’s test was
also used in the biomarkers data to compare challenged groups
with the CNT group. For feed intake, each pen was used as an
experimental unit, and for the remaining analyses, each bird was
used as an experimental unit. Due to the low number of
experimental units (3 pens per treatment), feed intake was
only used as a clinical sign and not to compare performance
between groups. Software JMP® Pro 15.0.0 (SAS Institute Inc.)
was used, and for all tests P-value <0.05 was considered
statistically significant.Frontiers in Immunology | www.frontiersin.org 5RESULTS
Chronic Inflammation Model
Macroscopic Gut Observations
It was observed that neither the DSS treatment nor the rice bran
diet had an effect on feed intake or mortality (“Supplemental
Data”- Table 2). However, necropsy revealed intestinal lesions in
birds treated with DSS or fed the rice bran diet (Table 4). By the
macroscopic “I See Inside” method, NSP exhibited a more
consistent pattern of inflammation which negatively affected
the intestinal health as seen by the significantly higher
macroscopic lesion scores on days 14 and 36 with a similar
trend on days 22 and 28 (Table 4). Both DSS cycles and the high
NSP diet induced localized intestinal lesions, but no gross
inflammatory lesions in extra-intestinal organs (pancreas, yolk-
sac, liver, gizzard and proventriculus) were observed. Moreover,
the macroscopic ISI score lesions of each section of the intestine
showed that the duodenum was affected more in the early days of
the treatments (Table 5) whereas, the posterior parts of the
intestine showed compromised intestinal health at a later stage
(36 days), suggesting a spatial and temporal impact on the
intestinal lumen.
Microscopic Histological Gut Observations
and Alterations
The histological examination of the intestine provided us more
detailed and sensitive information about the gut status of the
broilers. The microscopic ISI revealed a clear spatial and
temporal impact of the treatments in the intestinal lumen.
Histologically, the ileum of the birds was affected later, after 28
days, while duodenum and jejunum presented inflammation
already in the first necropsy at 14 days of age (Figures 2–4).
The NSP diet induced higher microscopic ISI scores than the
CNT. These difference started to be seeing at 22-d in the
duodenum and at 14-d in the jejunum, followed by a
stabilization ISI score in these segments by 36-d (Figures 2
and 3). However, histological alterations in ileal tissue did not
appear until 28-d of NSP diet consumption (Figure 4). The mainTABLE 4 | Macroscopically I See Inside (ISI) lesions scores of related organs, intestine and total score of broilers submitted to different intestinal challenges at 14, 22, 28
and 36 days of age. The broilers challenged with DSS received 0.25mg/ml (25DSS) or 0.35mg/ml (35DSS) of DSS via oral gavage everyday from 9 to 14-d and 23 to 27-d;
birds in the NSP treatment received a diet with 30% of rice bran during the whole experiment, and animals in the control group were not submitted to any challenge.
Treatment 14 days 22 days 28 days 36 days
Related organs intestine Total Related organs Intestine Total Related organs Intestine Total Related organs Intestine Total
Control 4.83 5.66 b 10.50b 2.66 5.00 7.66 2.16 5.50 7.66 1.83 1.50 b 3.33
25DSS 4.50 9.33 ab 14.16ab 3.33 5.50 8.83 2.33 9.33 11.66 1.00 4.83 ab 5.83
35DSS 5.16 10.66 ab 15.83ab 1.83 7.16 9.00 2.66 6.16 8.83 1.83 3.50 b 5.33
NSP 4.83 13.66 a 18.50a 3.66 6.33 10.00 2.50 9.66 12.16 0.83 7.83 a 8.66
SEM1 1.224 1.686 1.804 0.850 1.139 1.285 0.677 1.381 1.770 0.7216 1.0672 1.4912
P-value 0.985 0.024 0.036 0.456 0.563 0.651 0.958 0.098 0.241 0.656 0.003 0.122May 2021 | Volume 12 | ArticleRelated organs evaluated: liver, yolk sac, proventriculus, gizzard, pancreas.
ab Different superscript letters indicate significant difference with Tukey test.
1 Pooled standard error of the mean.
Maximum macroscopic ISI score: Related organs 24; Intestine 54; Total 78.
n= 6 animals/treatment; 2 animals/pen.676628
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increased infiltration of inflammatory cells in the lamina
propria and epithelium which also seemed to shift in a
temporal (from 14-d to 26-d) and spatial fashion (from
duodenum towards ileum; Supplemental Data- Tables 3–5).
At later stages of growth (22-d to 36-d), an increase in epithelial
and lamina propria thickness was also observed (Supplemental
Data- Tables 3–5). Broilers fed the NSP diet also had a variation
in the goblet cells probably as a response to the mucus
production by the intestine. Goblet cells were initially (14-d)
reduced in the duodenum in this treatment compared to control
(P < 0.0001), but at 22 and 28-d of age broilers showed an
increase in goblet cells at duodenum and jejunum (P<0.01;
Supplemental Data- Tables 3, 4) (Supplemental Data- Table
5). This goblet cell response was stabilized at 36 days of ageFrontiers in Immunology | www.frontiersin.org 6(P < 0.0001; Supplemental Data- Table 6). Moreover, birds fed
with the high NSP diet presented an increased abnormal
proliferation of enterocytes which was constant in the jejunum
throughout the experiment, and affected the whole small
intestine by 28 days (Supplemental Data- Tables 3–6).
The chemical model of low-grade inflammation (two cycles of
DSS) also was able to reduce intestinal health as indicated by the
increase in the ISI histological scores. The duodenal and jejunal
tissue were already affected by the first DSS cycle (Figures 2, 3),
but the ileum showed a significant increase in ISI only after the
second DSS challenge. Even after 9 days of recovery, the
duodenum and jejunum had higher ISI scores than the control
(Figures 2, 3) and after the second DSS cycle (28-d), the birds
presented several histological alterations diffused in the small
intestine showing an additive effect of the cycles over the time.TABLE 5 | Macroscopically I See Inside lesions scores of duodenum (Duod), jejunum (Jejun), ileum and ceca of broilers submitted to different intestinal challenges at
14, 22, 28 and 36 days of age. The broilers challenged with DSS received 0.25mg/ml (25DSS) or 0.35mg/ml (35DSS) of DSS via oral gavage everyday from 9 to 14-d
and 23 to 27-d; birds in the NSP treatment received a diet with 30% of rice bran during the whole experiment, and animals in the control group were not submitted to
any challenge.
Treatment 14 days 22 days 28 days 36 days
Duod Jejun Ileum Ceca Duod Jejun Ileum Ceca Duod Jejun Ileum Ceca Duod Jejun Ileum Ceca
Control 1.5b 2.00 1.33 0.83 1.5 0.66 1.50 1.33 1.66 1.50bc 1.5 0.83 0.66 0.00 b 0.166c 0.66
25DSS 2.66b 2.83 1.50 2.33 2.33 0.83 0.66 1.66 1.83 3.50b 1.5 2.5 2.00 1.83ab 0.5bc 0.50
35DSS 3.83ab 3.16 1.83 1.83 1.66 2.00 1.33 2.16 1.66 0.66c 1.66 2.16 0.66 0.83b 1.00ab 1.00
NSP 5.66a 3.16 2.66 2.16 0.33 3.00 1.50 1.50 1.66 4.00a 3.00 1.00 0.83 3.66 a 2.00a 1.33
SEM1 0.8113 0.5809 0.540 0.631 0.667 0.606 0.383 0.524 0.554 0.709 0.621 0.509 0.602 0.747 0.263 0.318
P-value 0.0157 0.4338 0.4932 0.3789 0.1891 0.0907 0.3314 0.714 0.9955 0.0164 0.3016 0.0535 0.3481 0.0240 0.0042 0.2881May 2021 | Volume 12 | Articleab Different superscript letters indicate significant difference with Tukey test.
1 Pooled standard error of the mean.
n = 6 animals/treatment; 2 animals/pen.FIGURE 2 | I See Inside (ISI) total microscopically lesions scores of duodenum of broilers submitted to different intestinal challenges at 14, 22, 28 and 36 days of
age. The broilers challenged with DSS received 0.25mg/ml (25DSS) or 0.35mg/ml (35DSS) of DSS via oral gavage everyday from 9 to 14-d and 23 to 27-d; birds
in the NSP treatment received a diet with 30% of rice bran during the whole experiment, and animals in the control group were not submitted to any challenge.
abc Different superscript letters indicate significant difference with Tukey test. n = 6 animals/treatment; 2 animals/pen.676628
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evaluated parameters were elevated. The duodenum, jejunum
and ileum presented higher scores for lamina propria and
epithelial thickness, proliferation of enterocytes, and
infiltration of inflammatory cells in epithelium and lamina
propria than CNT (Supplemental Data- Table 5). Moreover,Frontiers in Immunology | www.frontiersin.org 7an increase in goblet cells is observed in duodenum and jejunum
at that time point.
Lastly, the ISI scores of the 35DSS treatment were higher
across all intestinal segments at 36 days showing a decreased
intestinal health even after 9-d of recovery from the second DSS
cycle. At the end of the experiment, animals in the 35DSS groupFIGURE 3 | I See Inside (ISI) total microscopically lesions scores of jejunum of broilers submitted to different intestinal challenges at 14, 22, 28 and 36 days of age.
The broilers challenged with DSS received 0.25mg/ml (25DSS) or 0.35mg/ml (35DSS) of DSS via oral gavage everyday from 9 to 14-d and 23 to 27-d; birds in the
NSP treatment received a diet with 30% of rice bran during the whole experiment, and animals in the control group were not submitted to any challenge. abc Different
superscript letters indicate significant difference with Tukey test (P < 0.05). n = 6 animals/treatment; 2 animals/pen.FIGURE 4 | I See Inside (ISI) total microscopically lesions scores of ilea of broilers submitted to different intestinal challenges at 14, 22, 28 and 36 days of age. The
broilers challenged with DSS received 0.25mg/ml (25DSS) or 0.35mg/ml (35DSS) of DSS via oral gavage everyday from 9 to 14-d and 23 to 27-d; birds in the NSP
treatment received a diet with 30% of rice bran during the whole experiment, and animals in the control group were not submitted to any challenge. abc Different
superscript letters indicate significant difference with Tukey test (P < 0.05). n = 6 animals/treatment; 2 animals/pen.May 2021 | Volume 12 | Article 676628
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epithelium as well as a consistent increase in globet cells in all
intestine segments (P-value < 0.05), higher lamina propria and
epithelial thickness in jejunum and ileum (P-value < 0.01), and
increased enterocytes proliferation in the jejunum (P-value = 0.0003;
Supplemental Data). Thus, the histological alteration indicates that
even following 9 days of recovery, two cycles of 0.35mg/ml of DSS
were able to induce a long-lasting inflammation.
Therefore, both the high inclusion of rice bran and the two
DSS models proved successful in producing chronic intestinal
inflammation. The NSP diet induced a marked inflammatory
response through the first 28 days of broiler age whereas, theFrontiers in Immunology | www.frontiersin.org 8birds showed a partial reduction of the intestinal inflammation
when they aged (observed at 36-d). Additionally, the NSP diet
produced a lower-grade inflammation when compared to the
DSS treatments, the latter presenting consistently a higher ISI
score (Figures 2–4). The two DSS cycles of 0.35mg/ml produced
a long-lasting inflammation persistent even after 9 days of
recovery and presented a more consistent microscopic pattern
than the 0.25mg/ml DSS challenge. However, independent of the
trigger, the inflammation response of the broilers showed a
similar pattern and the intestinal inflammation progressed
from the cranial segments of the small intestine to the caudal
areas through time (Figure 5).FIGURE 5 | Temporal and spatial evolution of the intestinal inflammation response triggered by a high non-starch pollisacharyde diet (NSP) diet or a DSS challenge
in broilers. Areas painted with red and/or blue signalizing the affected* areas in birds fed NSP diet (red) or in birds challenged with the DSS protocol (blue). *affected
areas: areas with poor intestinal health (higher microscopic ISI scores).May 2021 | Volume 12 | Article 676628
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Calprotectin, lipocalin and LPS were analyzed in the serum of
broilers but the only serum biomarker that showed a statistical
difference in the challenged groups was calprotectin (CALP)
(Table 6). The concentration of CALP in the blood was higher in
the presence of intestinal inflammation (P-value = 0.0365) at 14
days of age. Calprotectin concentration in the serum was 135%
higher in animals from the 35DSS group when compared with
control birds. However, after the recovery period (at 22-d) of the
first DSS cycle, the difference in calprotectin concentration of both
groups disappeared. The rice bran presented a CALP elevation of
60.9% but it was not sufficient to be different than the CNT at 14-d.
In addition, calprotectin concentration in the serum might be
age-dependent. A 10-fold increase of calprotectin concentration in
the serum was found in all treatments between days 14 and 22
(Table 6). The serum concentrations of lipocalin and LPS were not
statistically different among the treatments at any of the timepoints
measured (Table 7 and Supplemental Data-Table 7, respectively).
Among the analyzed fecal biomarkers, calprotectin and
lipocalin showed statistical differences among treatments at day
28 (P-value = 0.0395 and P-value=0.0075, respectively; Table 8).
After the second cycle of DSS, the 35DSS-treated birds showed
an increase in fecal calprotectin concentration when compared to
the control by 24.99%. DSS (25DSS) and NSP treatments had a
numerical increase in fecal calprotectin concentration but no
statistical difference compared to the control. Broilers fed the
high NSP diet also showed a statistical increase in fecal lipocalin
concentration (27.09%) (P-value = 0.0075). However, by 36 daysFrontiers in Immunology | www.frontiersin.org 9of age, no differences were observed in either fecal calprotectin or
lipocalin concentrations, suggesting there is an optimal time to
analyze the markers or that the numbers of samples were not
enough to detect differences among treatments in older birds.
Interestingly, fecal HIF-1a presented a tendency (P-value=0.062)
at 36 days of age with 35DSS showing the highest concentration.
No differences were observed in the concentration of fecal S100
at any day analyzed or fecal ovotransferrin at 28-d (Table 8 and
Supplemental Data Table 8, respectively).DISCUSSION
Inflammation Model: DSS and NSP
The present data revealed that the intestinal mucosal reaction
(i.e. inflammation) to stressors followed a spatial and temporal
pattern in broilers, from the duodenum to the ileum from 14 to
36 days post-hatch (Figure 5). The histological assessment
indicated that the duodenum and jejunum were affected earlier
than the ileum. Thus, it seems that the lower part of the gut was
affected only after the upper gut was compromised in terms of
intestinal health (Figures 2–4). Duodenum and jejunum had
signs of injury at the first necropsy (14-d). However, indications
of acute inflammation, such as the presence of inflammatory cells
in the lamina propria and epithelium were observed in the ileum
from day 22 and were maintained until the end of the experiment
in 35DSS and NSP groups. Evidence of a higher upper gutTABLE 6 | Calprotectin concentration in the serum of broilers submitted to different intestinal challenges at 14 and 22 days of age.
Treatment 14 days 22 days
Calprotectin (ng/ml) ± S.E.M. Calprotectin (ng/ml) ± S.E.M.
Control 16.86 b 1.74 221.34 36.61
25DSS 21.14 ab 2.86 188.49 19.33
35DSS 39.68 a* 8.29 232.47 21.17
NSP 27.13 ab 4.81 203.79 18.83
P-value 0.0365 0.6562May 2021 | Volume 12 | Artic* Treatments differ from Control by Dunnet’s test (P-value<0.05).
abc Different superscript letters indicate significant difference with Tukey test in the same column.
n= 6 animals/treatment; 2 animals/pen.
DSS: Dextran sodium sulfate; NSP: non-starch polyssacharide
The broilers challenged with DSS received 0.25mg/ml (25DSS) or 0.35mg/ml (35DSS) of DSS via oral gavage everyday from 9 to 14-d and 23 to 27-d; birds in the NSP treatment received
a diet with 30% of rice bran during the whole experiment, and animals in the control group were not submitted to any challenge.TABLE 7 | Lipocalin concentration in the serum of broilers submitted to different intestinal challenges at 14, 22 and 28 days of age.
Treatment 14 days Lipocalin (ng/ml) ± S.E.M. 22 days Lipocalin (ng/ml) ± S.E.M. 28 days Lipocalin (ng/ml) ± S.E.M.
Control 85.60 3.66 90.06 7.83 50.21 6.28
25DSS 95.49 3.39 93.53 8.58 53.85 3.99
35DSS 86.67 4.70 94.85 7.83 48.8 5.46
NSP 86.86 2.97 84.72 7.83 60.36 4.64
P-value 0.2463 0.8061 0.4188n= 6 animals/treatment; 2 animals/pen.
DSS: Dextran sodium sulfate; NSP: non-starch polyssacharide.
The broilers challenged with DSS received 0.25mg/ml (25DSS) or 0.35mg/ml (35DSS) of DSS via oral gavage everyday from 9 to 14-d and 23 to 27-d; birds in the NSP treatment received
a diet with 30% of rice bran during the whole experiment, and animals in the control group were not submitted to any challenge.le 676628
Dal Pont et al. Intestinal Inflammation and Biomarkers in Chickenssensitivity has already been described in broilers exposed to heat
stress with greater histo-morphological and morphometric
alteration observed in the duodenum and jejunum (37).
Therefore, the stronger inflammatory response of the upper
gut might be not related to the stressor source, since it
happened with NSP rich diet, chemical (DSS) and even heat
challenge. However, the spatial characteristics of intestinal
inflammation verified in the present study contrasted with
findings in the murine model. Previous research showed that
the distal colon of mice is more affected by DSS challenge than its
proximal colon (38–41).
Overall, NSP exhibited a more consistent pattern of
inflammation during the trial although it was milder when
compared with the DSS-treated birds (Figures 2, 3). NSP
negatively affected intestinal health, as seen by the significantly
higher macroscopic ISI score as well as the microscopic lesion
scores (Table 5 and Figures 2, 3).
DSS challenge promoted higher levels of micro-ISI scores in the
duodenum than control (P<0.001) throughout the entire
experiment (Figure 2). And at the last day of sampling (36-d),
the 35DSS group presented the worst (highest) ISI scores
throughout the small intestine. The higher ISI scores were mainly
due to the high inflammatory cell infiltration in the lamina propria
and epithelium. DSS groups showed a consistent increase in the
number of goblet cells through the end of the trial (28 and 36-d).
The DSS model proposed in this paper was adapted to chickens
based on a mice model for chronic inflammation (23). These
authors observed that mice recovered faster from the first DSS
cycle (9-d) but, after the second round of chemical oral gavage 9-d
was not enough to have a full recovery from the inflammation
caused by DSS. Our study demonstrated that broilers exposed to a
similar protocol presented a major intestinal inflammation in the
second DSS cycle as was observed in the murine model (23).
However, for broilers, 9 days was not sufficient for full recovery
from the first challenge cycle. Since chickens appear to be more
sensitive to oral DSS (10), the current observation is not surprising.Frontiers in Immunology | www.frontiersin.org 10Moreover, in mice the inflammatory response after the second
recovery period is different from the response after de first recovery.
After two cycles of DSS and the full recovery period, mice presented
a chronic inflammation identified by the infiltration of
mononuclear cells, and imbalance of pro and anti-inflammatory
response. Although in the present study, we did observe a prolonged
inflammatory response in the three intestinal segments evaluated
even after the second recovery, we did not categorize and quantify
the inflammatory cells and cytokines present in the intestine at each
time point.
In the current experiment, all the challenged groups presented
a high level of enterocyte proliferation and inflammatory cell
infiltration in the epithelium of the small intestine at 28 days.
Sanches and colleagues (8) observed that during inflammation the
avian intestine responds to the lesions in the lamina propria
mostly with a strong proliferation of enterocytes that further
stimulates the inflammatory response since these new enterocytes
are not mature. They also described a microscopic proliferative
enteritis in broilers with Eimeria spp. and Clostridium perfringens,
confirming this pattern.
Furthermore, the current data suggest that histologic
methodologies are superior to the evaluation of gross lesions for
small intestine inflammation in research settings. Other than its
precision and ability to provide details, a histologic evaluation
may be crucial to detect Microscopic Enteritis (ME). Human
pathology uses ME as a classification for an inflammatory
condition of the small intestine which presents microscopic or
sub-microscopic abnormalities but not gross lesions (42). The
histological observations in ME include preserved villous
structure, crypt hyperplasia (deeper crypt), infiltration of small
lymphocytes in the epithelium, sub-microscopic abnormalities,
increase in plasma cells and inflammatory cells in the lamina
propria also may be present. Even if the lesions appear minor, ME
is associated with gastrointestinal symptoms, and malabsorption
(43). Microscopic enteritis was already identified in broilers
through microscopic ISI evaluation (8), and Belote et al. (33)TABLE 8 | Biomarker concentration on excreta of broilers submitted to different intestinal challenges at 28 and 36 days of age. The broilers challenged with DSS
received 0.25mg/ml (25DSS) or 0.35mg/ml (35DSS) of DSS via oral gavage everyday from 9 to 14-d and 23 to 27-d; birds in the NSP treatment received a diet with
30% of rice bran during the whole experiment, and animals in the control group were not submitted to any challenge.
Collection day Treatment Calprotectin (ng/g) ± S.E.M. Lipocalin (ng/g) ± S.E.M. S100A (ng/g) ± S.E.M. HIF-1a (pg/g) ± S.E.M.
28 Days Control 5168.6 b 238 3557.44b 264.8 118.7 5.49 1195.2 53.6
25DSS 5705.1 ab 246.9 3383.49b 186.1 103.9 3.6 1158.3 38.72
35DSS 6460.7 a* 88.53 3693.66ab 253.5 108.1 8.9 1063.9 104.6
NSP 5986.8 ab 413.7 4521.49a* 96.9 93.9 7.98 990.5 91.86
P-value 0.0395 0.0075 0.1281 0.28
36 Days Calprotectin ± S.E.M. Lipocalin (ng/g) ± S.E.M. S100A (ng/g) ± S.E.M. HIF-1a (pg/g) ± S.E.M.
Control 6176.4 488.3 1039.6 133.6 166.39 17.67 143.3 28.15
25DSS 6321.7 725.4 1252.2 131.2 181.4 22.36 244.7 20.73
35DSS 6171.7 485.6 1156 154.3 160.6 16.32 249.6 24.93
NSP 6365.7 480.4 1360.6 141.7 135.7 8.64 225 39.6
P-value 0.992 0.4364 0.3174 0.0627May 2021 | Volume 12 | Artic*Treatments differ from Control by Dunnet’s test (P-value < 0.05)..
abc Different superscript letters indicate significant difference with Tukey test in the same column.
n = 6 animals/treatment; 2 animals/pen.
DSS, Dextran sodium sulfate; NSP, non-starch polyssacharide.le 676628
Dal Pont et al. Intestinal Inflammation and Biomarkers in Chickenshave shown that the increase of inflammatory cells in the
epithelium has a negative impact on animal performance by
reducing growth performance.
Biomarkers
The poultry industry is constantly looking for tools to measure gut
health in order to evaluate flocks and decide when to use feed
additives or medications. Moreover, these tools should be: (1) able
to provide a rapid answer to allow intervention during the
production period; (2) minimally invasive; and (3) easy to
collect and store the required samples. Several ways to identify
gut inflammation and/or gut health are available for research
settings; however, most require tissue sampling and euthanasia of
animals. Thus, blood and excreta were chosen in the current
experiment to fulfill the 2nd and 3rd requirements. Moreover,
ELISA assays were selected for their relative simplicity in
methodology, low requirement in lab equipment, quick
generation of results, high specificity and easy commercial
access. It is believed that the relevant findings from this research
will facilitate further research in different labs including
widespread industry application. ELISA assays offer an
additional advantage over molecular methods (i.e. mRNA gene
expression) in the sense that the targeted biomarker refers to
finally expressed (protein) levels, which is not the case in the latter.
From the biomarkers evaluated in the current experiment,
calprotectin was observed to be the most promising.
Calprotectin, also known as S100A8/S100A9 heterocomplex, is
a protein involved in the innate immune response to infection. It
activates pro-inflammatory signaling pathways and has
chemokine and bacteriostatic activity (44–47). Avian and
reptile species express a protein homologue to calprotectin,
named MRP126. This protein has already been found in
abundance in chicken heterophils and in lower quantities in
macrophages (48, 49). Recently, the chicken MRP126 has been
biophysically described by Bozzi and Nolan with important
observation of its metal binding (Ca+2-dependent Zn+2
sequestration) and antimicrobial property activities (50).
Moreover, recombinant chicken MRP126 had been shown to
stimulate chicken TLR4 to activate NF-kB (51). Therefore, it
appears that the cytokine-like and bacteriostatic activity of
MRP126 protein was maintained during evolution. A previous
study has shown that neutrophils release calprotectin with
activation or death and monocytes release the protein after
adhesion (52). Thus, calprotectin can be detected in fluids of
inflamed tissue, such as serum, urine, cerebrospinal fluid and
feces (53). Sekelova and collaborators (49) observed that the
abundance of MRP126 protein increase in avian macrophages
after intravenous infection with Salmonella Enteritidis.
Therefore, the increased calprotectin from blood and feces
found in the current study might be correlated to the immune
response of the challenged groups. The microscopic ISI scores
and the histologic alterations indicate the presence of an
inflammatory response in the intestine, specifically identified
by the increase in inflammatory cells in epithelium and lamina
propria, and congestion. Although fluctuations were observed
throughout the experimental period, calprotectin was increasedFrontiers in Immunology | www.frontiersin.org 11only right after the DSS cycles. Two factors can play a role in this
finding: first, calprotectin is more abundant in heterophils, and
second, the number of animals sampled may not be sufficient to
detect small variations in the concentration of proteins after the
recovery period. Heterophils are the first immune cells to
respond and migrate to a site of infection (54) and are found
in great quantity in acute inflammation. However, with the
evolution of acute to chronic inflammation more mononuclear
cells are identified with macrophages being the predominant cell
type in chronically inflamed tissues (55). Thus, the change in cell
type predominance at the moment of the sampling may have
influenced the calprotectin concentration, suggesting the protein
as an indicator of more robust inflammation. Calprotectin may
be a promising biomarker for inflammation in broiler measured
both in serum and excreta.
The ideal biomarker should also detect inflammation
consistently in different models, such as physiological and
nutritional models (13); therefore, in the current study, we also
analyzed biomarkers previously described in the literature such
as LPS, ovotransferrin and lipocalin-2. Lipocalin 2 is an acute
phase protein highly produced by the liver (56) and neutrophils,
although the majority of LCN2 found in the intestine is produced
by epithelial cells which mostly secrete the protein into the lumen
(57). Similar to calprotectin, lipocalin inhibits bacterial growth
by sequestering nutrients from the bacteria, such as iron (56),
and it also is involved in apoptosis (58). Chassaing and
collaborators (59) reported that fecal LCN-2 is a sensitive
marker capable of monitoring low-grade (sub-clinical) and
robust intestinal inflammation in mice since the protein
showed responsiveness to mucosal healing and high stability in
the feces. The authors observed an increase in fecal LCN-2 after
challenging mice with different dosages of DSS in the drinking
water, and when the challenge was discontinued, LCN-2
dramatically decreased its concentration. However, they
observed that lipocalin concentration in the serum was less
responsive to the DSS challenge, being a better detector of
robust intestinal inflammation (caused by high doses of DSS).
Similarly, these current results show that LCN-2 appears to be a
better marker of low-grade inflammation in broilers in the feces
than in the serum. In the present trial, broilers fed for 28 days
with the NSP showed higher fecal lipocalin at 28 days, compared
to the control group. However, with the healing of the upper gut
after the first recovery period, LCN-2 returned to basal levels,
indicating LCN-2 as a potential fecal biomarker for the health
status of upper gut segments. Previously, it has been reported
that fecal lipocalin in chickens (13) had a tendency (P=0.086) to
increase in a dexamethasone model of intestinal inflammation.
However, the lipocalin differences probably was less prominent
due to the control treatment used which had a diet with high
inclusion of wheat (65.2%). This diet may have negatively
impacted the gut due to its high soluble fiber content
promoting inflammation and reducing the differences between
control and other treatments in the study. Therefore, the current
data sustain previous findings in the literature and supports the
value of lipocalin as a biomarker for intestinal inflammation
in chickens.May 2021 | Volume 12 | Article 676628
Dal Pont et al. Intestinal Inflammation and Biomarkers in ChickensThe LPS present in the serum was quantified to detect
bacterial translocation from the intestinal lumen to blood, thus
evaluating intestinal barrier function. However, no difference
between challenge groups and control was found at 14, 28 or 36
days. The measuring of serum LPS in chickens is controversial in
the literature and it seems to vary according to the intensity of
the challenge to which birds are exposed (60–62).
Ovotransferrin, an acute phase protein mainly produced
during inflammation, has been suggested as a fecal biomarker
of intestinal inflammation due to its increase in excreta of
broilers facing necrotic enteritis and coccidiosis (25), or diet
with 52% of rye (13). However, in our study, no increase of fecal
ovotransferrin was detected in the groups suffering intestinal
inflammation, which might occur due to the sub-clinical
inflammation observed in the current study compared to the
acute and more robust inflammation produced by the other
models in the literature.
Lastly, HIF-1a is a transcription factor that regulates genes
involved in inflammation and cell death (63). HIF-1a has been
shown to be an important hypoxia-elicited barrier protection
through nonclassical barrier function (non-tight junctions
related) (64). Moreover, the HIF-1a pathway can be activated
by NF-kB, thus initiating inflammation and vice versa (64, 65).
Gene expression of HIF-1a has been measured in broilers facing
intestinal inflammation due to heat stress and an up-regulation
of the HIF-1a gene was detected in the ileum, but not jejunum
(66). Our results followed a similar response, since the HIF-1a
concentration presents a tendency to be increased in the feces of
broilers with lower ileum health status (P = 0.0627). Likewise, He
and collaborators (67) only observed intestinal upregulation of
HIF-1a expression after a chronic heat stress exposure (for 14
days), but not after 7 days of thermal challenge. Although HIF-
1a levels need to be further quantified in the excreta of broilers,
the HIF-1a seems to be a potential fecal biomarker for chronic
inflammation or ileal health status. Further experiments are
underway to confirm the use of HIF-1a as a potential
inflammatory marker.
The ideal biomarker has been described with several
characteristics: minimally-invasive, specific, precocious,
sensitive, robust, consistent among different challenge models
and responsive to tissue healing (13, 59, 68). However, an
important point that is usually missed is the practicality of
sampling and processing, and the time to produce results.
Although, authors advocate that fecal biomarkers should be
more accurate in determining gastrointestinal inflammation
and gut barrier (69), our data demonstrated that serum
biomarker (calprotectin) presented bigger differences (135%)
compared to fecal biomarkers (CALP and LCN-2) (~25%
increase). A biomarker with a broader range would permit a
better distinction among good gut health, low-grade and robust
inflammation. The difference between the biomarkers response
in serum and feces can be physiological, due to age and may be
associated with the difficulty of fecal processing, variation and
representativeness. The presence of proteases in the intestinal
content can diminish some proteins with biomarker potential
even before the excretion. Moreover, fecal samples are vulnerableFrontiers in Immunology | www.frontiersin.org 12to protein degradation and usually are flash frozen right after
sampling in liquid nitrogen and stored at -80°C (13, 25). This
methodology might impair successful collections in the field. In
our experiment, we observed easy handling and processing of the
blood samples, minimal equipment needed, combined with the
advantage of monitoring individual birds at the same time on
necropsy days. Therefore, to benefit the research performed in
industry settings, there should be a focus not solely on feces but
also on blood biomarkers, as well as to further evaluate
biomarkers stability in the samples throughout different
experimental situations.CONCLUSION
Both NSP diet and two cycles of 0.35mg/ml of DSS models
produced an inflammatory response in the intestine without
compromising other organs or producing clinical signs.
Therefore, this study presents feasible models of low-grade
chronic inflammation although the judgment between the
models should be made based on the time response desired
and the practicality. The high NSP diet is a nutritional model
which is easy to replicate and should be used if an early intestinal
inflammation is preferred (up to 28d). On the other hand, cyclic
DSS challenges is a chemical model which continues producing
inflammation later in the broiler’s life (up to 36d). Interestingly,
the current study demonstrated that the chicken intestinal
inflammation evolves in a spatial and temporal pattern, shown
by the lower small intestine being affected later than the upper
parts. After a challenge, the duodenum and jejunum were
affected earlier, followed by the ileum which was compromised
only after 4-wk of the life span of the chicken. Moreover, this
physiological response might not vary with the stressor’s
characteristic since it was consistent between a nutritional-
continuous challenge and a cyclic-chemical model.
Lastly, we described promising biomarkers for low-grade
intestinal inflammation in the current paper such as
calprotectin, lipocalin and HIF-1a. Calprotectin, a novel
biomarker for chickens, was successfully detected in response
to inflammation from serum and feces, while HIF-1a and
lipocalin may be potential fecal markers. To the best of our
knowledge, this is the first time that calprotectin has been
described as a biomarker of intestinal health in broiler
chickens. Even more promising, is the fact that it can be easily
analyzed in the blood and be correlated with intestinal health,
which may reduce the variation between birds, be less time-
consuming, and reduce the risk of degradation during
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